Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
TMEM231 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
SOCS7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
USP11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAP3K12 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RTN4IP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RBCK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C21orf33 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC100996740 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
DHTKD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SEPHS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KCNAB2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IL27RA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KIAA1549 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KDM7A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DAP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LCMT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRPM7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBN2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FANCI - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on